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TECHNICAL NOTE
Three exchanges with a 2.5-liter volume for continuous
ambulatory peritoneal dialysis
ZBYLUT TWARDOWSKI and LUCYNA JANICKA
Department of Nephrology, Institute of Internal Medicine, School of Medicine, Lublin, Poland
Continuous ambulatory peritoneal dialysis (CAPD) is the
continuous presence of dialysis solution in the peritoneal cavity
except for brief periods of fluid exchanges. Long-dwell ex-
changes allow equilibration of small molecular-weight solutes
between plasma and dialysate, so that clearances of these
solutes are essentially equal to drainage volumes in a particular
period. Originally five exchanges with 2 liters of dialysis
solution were used, yielding daily drainage volumes of 10.9 to
11.7 liters [1]. Oreopoulos et al 2] found four 2-liter exchanges
per day sufficient in most patients to achieve good biochemical
control of uremia. Increasing the volume of dialysis solution
instilled into the peritoneal cavity would augment efficiency of
dialysis with the same frequency of exchanges or would allow
the number of exchanges to be reduced yet retain the efficiency.
In the present study, we used three exchanges per day with
2.5 liters of dialysis solution. Mainly three concentrations of
glucose were used: 1.5%, 2.4%, and 3.3%. Occasionally, a
dialysis solution with a 4.2% glucose concentration was used.
The total exchange time (diffusion time, cycle time) varied from
2 to 14 hours. The aim of this preliminary study was to ascertain
whether such a volume instilled into the peritoneal cavity could
be tolerated by patients and could yield sufficient ultrafiltration.
Methods
Patients in this study had chronic renal failure, and they were
on chronic peritoneal dialysis (intermittent or continuous) with
four 2-liter exchanges per day. Clinical characteristics of these
patients are shown in Table 1.
Peritoneal dialysis solutions in 0.5-liter bottles (Polfa, Lublin)
contained (per liter) 139 mEq of sodium, 4.0 mEq of calcium,
1.5 mEq of magnesium, 99.5 mEq of chloride, 45 mEq of
acetate, and also 1.5% glucose (fluid no. I) or 6.0% glucose
(fluid no. 2). The mean volume of fluid I from commercially
available bottles with a nominal content of 500 ml, as measured
several times for different series, was 507 (SD) 14 ml (N = 60),
and of fluid 2 was 525 12 ml (N = 50). The pH of the solutions
ranged from 6.0 to 6.2. No additives were used, and the fluids
were prewarmed to body temperature before instillation. Four
concentrations of glucose were used during the study. Compo-
sitions and volumes of these solutions are shown in Table 2.
To achieve the greatest possible accuracy in measurements of
drainage volumes and cycle times, we carried out the studies in
the hospital. The studies were performed at least I week after
the start of peritoneal dialysis with 2.5-liter exchanges in
patients without signs of peritonitis. Three exchanges per day
were used with several different schedules of cycle time and
glucose concentrations. Exchanges were designated with four-
digit numbers. The first two digits stood for cycle time, and the
last two digits for glucose concentration, for example, 0233
means two hours of cycle time with a glucose concentration of
33 g/liter. Table 3 shows time schedules used in the study. Only
values from days 1, 2, and 3 were used for calculations. After
each period, continuous dialysis was carried out for several
days with glucose concentrations adjusted according to the
patients' needs. If patients wished, and ultrafiltration volumes
were close to the volumes desired, the study periods were
internipted only with days "0". As can be seen in Table 3, a
particular total exchange time with specific glucose concentra-
tion was included in three different time schedules following
exchanges of different durations and glucose concentrations.
Serum urea, creatinine, calcium, sodium, potassium, and
phosphorus were estimated by routine laboratory methods.
In all patients, measurements of vital capacity with a spirom-
eter were performed, with patients in sitting position, just
before drainage, after complete drainage, after infusion of four
bottles, and after infusion of five bottles. The patients tolerating
the 2.5-liter volume had at least ten measurements; in the other
patients, only one to six measurements were done.
The mean values presented in the figures, the tables, and
used in statistical analysis were calculated from the means for
each patient. A Pearson correlation coefficient and Student's
unpaired or paired t tests, where appropriate, were applied to
test the null hypothesis if the observed differences or correla-
tions were significant. In cases where the Snedecor test indicat-
ed that variances in two samples were critically different, the C
test (C) of Cochran and Cox instead of a Student's t test was
applied.
Results
Tolerance of the 2.5-liter volume instilled into the peritoneal
cavity is shown in Table 4. The mean body surface area of the
patients not tolerating this volume did not differ significantly
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Table 1. Patient characteristics
Patient
No. Sex
Weight
Age Diagnosis kg
Height
cm
Urine
volume
ml
F
2 M
3 M
4 M
5 F
6 M
7 F
8 M
9 M
10 M
11 M
12 F
13 M
14 F
15 M
16 F
Mean SD
32 Malignant nephrosclerosis 44.5
25 Chronic glomerulonephritis 61.0
57 Chronic interstitial nephritis 66.5
23 Alport's syndrome 63.5
48 Chronic glomerulonephritis 59.5
43 Malignant nephrosclerosis 66.0
54 Obstructive nephropathy 66.5
18 Cystic medullary disease 50.0
29 Malignant nephrosclerosis 72.0
24 Chronic glomerulonephritis 78.5
28 Chronic glomerulonephritis 73.5
24 Chronic glomerulonephritis 55.0
45 Chronic glomerulonephritis 73.0
26 Cystic medullary disease 41.5
59 Obstructive nephropathy 84.5
57 Polycystic renal disease 60.0
37.0 14.4 63.5 11.8
161
176
166
176
163
167
156
164
176
180
180
168
172
151
174
159
168 9
250
350
400
650
350
350
300
350
100
250
250
200
50
100
350
550
303 156
Table 2. Compositions and mean volumes of dialysis solutions
Glucose concentrations per liter
15g 24g 33g 42g
No. of bottles of fluid la
No. of bottles of fluid 2b
Osmolality, mOsm/liter
Volume, ml
5 4 3
0 1 2
370 420 470
2535 2553 2571
2
3
520
2589
a 1.5% glucose (see Methods)b 6.0% glucose (see Methods)
from that of patients that did tolerate it (C = 0.466; C005 =
4.183). Those patients who did not tolerate the 2.5-liter volume
had the lowest vital capacity values. The differences of the
means were highly significant by the C test of Cochran and Cox
(all C's higher than C001). The highest values of vital capacity
were found just after drainage from a preceeding exchange. In
patients of group 1, instillation of 2 liters of fluid diminished the
mean value by 140 ml (3.70%). The difference was significant by
the one tailed paired t test (t = 2.08; P = 0.030). If the infused
volume was increased to 2.5 liters, vital capacity was decreased
further by 99 ml, that is, 2.72% (t = 2.52; P = 0.013) compared
with the values from 2 liters of fluid. In patients of group 2, the
observed decrease in vital capacity was even greater, compar-
ing values after 2 liters to values after 2.5 liters (6.81%), but too
small a sample excluded the possibility of statistical analysis. In
patients of group 1, the mean vital capacity before exchange
was almost identical to that after infusion of 2 liters of fluid. The
mean drainage volume was 2843 ml (range, 1800 to 3900 ml)
during exchanges when vital capacity was measured.
Patients 1 to 10 completed all seven periods of cycle time
presented in Table 3. Figure 1 shows ultrafiltration with solu-
tions of 15, 24, and 33 g of glucose related to cycle time in these
patients. The highest values with 15-g and 24-g glucose solu-
tions were observed after 4 hours, whereas with the 33-g
solution, the highest values were after 6 hours. After peak
values were obtained, the mean rates of absorption of fluids
were very similar for all kinds of solutions, as reflected by
corresponding slopes of linear regressions (Fig. 1). There was a
great variation among patients in ultrafiltration rates as revealed
by the high values of SEM. The rates of absorption differed also
markedly among patients. In patient 4, the peak values of
ultrafiltration were observed after 6 hours, and the slopes of
linear regressions for l5-g, 24-g, and 33-g glucose solutions
were —8.30, —10.00, and —25.05 ml/hr, respectively, whereas
in patient 9 the peak values occurred after 4 hours, and the
analogous slopes were —63.57, —64.80, and —89.20 mI/hr.
In Table 3, the mean daily drainage volumes for several time
schedules for glucose concentrations are shown. The highest
values were obtained with even distribution of cycle times (day
3 of periods 1, 2, and 3), but the decrease of drainage volumes
with uneven time distribution was not pronounced.
All patients who tolerated 2.5-liter exchanges preferred them
for routine dialysis. The most popular schedules used at home
were: 0824—0615—1033; 0933—0515—1033; and 0824—0615—1024.
Glucose concentrations varied among patients depending on
ultrafiltration rates and residual urine volumes.
In patients 1 to 13, after 8 weeks of continuous dialysis with
three 2.5-liter exchanges per day, the average of the biochemi-
cal values were as follows (mean SD): urea, 118 39 mgldl;
creatinine, 10.5 2.4 mg/dl; sodium, 139.5 3.3 mEq/liter;
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Table 3. Cycle times and glucose concentrations for ultrafiltration study
Period Cycle time and glucose concentrations
Daily drainage volumea, ml
Mean SD
Period I
0 0824
Day 1 0215 1024 1233 8205 620
Day 2 0415 0624 1433 8475 880
Day 3 0815 0824 0833 8605 592
Period 2
0 0824
Day 1 0233 1015 1224 8325 447
Day 2 0633 0424 1415 8540 593
Day 3 0833 0824 0815 8570 506
Period 3
0 0833
Day 1 0224 1033 1215 8280 643
Day 2 0615 0433 1224 8385 644
Day 3 0824 0815 0833 8610 523
Period 4
0 0824
Day 1 1015 0224 1233 8390 63C
Day 2 0624 0415 1433 8425 485
Day 3 0215 1224 1033 8310 399
Period 5
0 0833
Day 1 0615 1424 0433 8290 575
Day 2 0233 1215 1024 8320 552
Day 3 0424 0633 1415 8615 514
Period 6
0 0815
Day 1 1415 0424 0633 8440 580
Day 2 1224 0215 1033 8290 435
Day 3 1433 0624 0415 8425 539
Period 7
0 0815
Day 1 1215 0233 1024 8225 476
Day 2 0615 0433 1424 8485 795
Day 3 1233 1015 0224 8151 430
Mean SD 8398 139
a The first 2 digits stand for cycle time, the last 2 digits for glucose concentration. Mean drainage volumes in patients I to 10 are also shown.
potassium, 4.4 0.6 mEq/liter; calcium, 4.4 0.5 mEq/Iiter;
phosphorus, 5.3 1.2 mg/dl.
Discussion
These studies show that the majority of patients can tolerate a
2.5-liter volume of dialysis solution instilled into the peritoneal
cavity. The size of patients does not seem to be the most
important feature in foreseeing tolerance of this volume. Much
more valuable appeared to be the vital capacity. Abdominal
distension and diminished appetite were frequent even among
patients who ultimately tolerated such a volume. Usually these
symptoms were not pronounced and disappeared approximate-
ly after 1 week of continued dialysis. Only three patients (out of
16) suffered from severe symptoms and could not be
"stretched." These patients had the lowest values of vital
capacity. Vital capacity was reduced slightly after infusion of
fluid into the peritoneal cavity depending on the volume of
instilled fresh dialysis solution. Not only volume but also some
element of irritation might play a role in this reduction because
the mean vital capacity before drainage was almost identical to
that observed after instillation of 2 liters of dialysis solution in
spite of roughly an 800-mi higher volume of dialysate present in
the peritoneal cavity. Some patients feel abdominal distension
even after instillation of 2 liters of fluid. Therefore, in our study
we tried the 2.5-liter volume after several weeks of dialysis with
2 liters when patients were already adjusted to this volume.
After several weeks of dialysis with 2.5 liters of fluid, the
patients did not feel discomfort even if incomplete drainage
occurred, and during the next exchange the volume of drained
dialysate was as high as 3900 ml. This observation suggests that
some patients can adjust to still larger volumes.
The highest ultrafiltration volumes occurred after 4 hours of
cycle time with 15-g and 24-g glucose solutions, and after 6
hours with the 33-g glucose solution. After peak values were
obtained, the mean rates of fluid absorption were 30, 39, and 42
mi/hr for these solutions. In the present study, net fluid removal
was sufficient for most patients with average glucose concentra-
tion of 24 g/iiter. Other concentrations, however, should be
available because there is a great variation in ultrafiltration
rates among patients. The best efficiency of ultrafiltration is
obtained with an even distribution of total exchange time, but
deterioration is not great with an uneven diffusion time schedule
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Table 4. Body surface area (BSA), vital capacity, and symptoms in patients tolerating (group 1), and not tolerating (group 2), the 2.5-liter
volume infused into the peritoneal cavity
BSA
m2
Vital capacity, ml
Symptoms
Before
drainage
After
drainage
After infusion
2 liters 2,5 liters
Group I patients
1 1.44 3620 3520 3080 3140 Diminished appetite for 1 week
2 1.75 3900 4340 4140 3920 Abdominal distension for 1 week
3 1.74 2625 2725 2750 2625 None
4 1.78 5200 5333 5466 5400 Abdominal distension for I week
5 1.64 2160 2360 2220 2240 Abdominal distension for I week
6 1.74 3172 3590 3363 3427 None
7 1.66 2254 2427 2181 2090 Abdominal distension, and
diminished appetite for I week
8 1.53 3420 3330 3560 3370 Abdominal distension, and poor
appetite for 2 weeks
9 1.88 5193 5240 5280 5133 None
10 1.98 4311 4405 4371 4270 None
11 1.93 4750 5100 4400 3950 None
12 1.62 3125 3240 3082 3145 None
13 1.86 3496 3618 3508 3401 None
Mean SD 1.735 3633 3787 3646 3547
Group 2 patients
14 1.33 1880 1900 1960 1860 Abdominal distension, vomitus,
loss of appetite
15 1.99 1966 2308 2167 1950 Abdominal distension, dyspnea,
poor appetite, insomnia
16 1.61 1900 2000 2000 1900 Abdominal distension, insomnia,
loss of appetite
Mean SD 1.643 1915 2069 2042 1903
within the limits of 2 to 14 hours. The most convenient cycle
time appears to be confined to 5 to 10 hours.
The advantages of reducing the frequency of exchanges are
selfevident. The most important seem to be greater freedom for
patients who can have uninterrupted working and sleeping
hours, less time spent to carry out the procedure, and dimin-
ished frequency of connections/disconnections, which should
decrease the risk of peritonitis.
Although presented data suggest that acceptable control of
serum chemistries can also be obtained, more information on
long-term results is needed to prove this technique to be
sufficient.
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Fig. 1. Ultrafiltration related to total exchange time with 15-, 24-, and
33-giliter glucose concentrations. Values are the means SEM. Linear
regressions are also shown.
